Publications by authors named "Ryan B Elliott"
J Oncol Pharm Pract
December 2017
Article Synopsis
- Bevacizumab is used in conjunction with other drugs like 5-fluorouracil, leucovorin, and oxaliplatin or irinotecan to treat metastatic colorectal cancer, offering a less toxic alternative to traditional chemotherapy.
- Despite its benefits, bevacizumab can lead to severe side effects, including serious complications like pulmonary embolism and gastrointestinal perforation.
- This report examines a specific case of a patient with advanced colon cancer experiencing these adverse effects, highlighting the associated risks, causes, and common symptoms of such complications.
